These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32928672)

  • 1. COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data.
    Macaluso FS; Orlando A
    Dig Liver Dis; 2020 Nov; 52(11):1222-1227. PubMed ID: 32928672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.
    D'Amico F; Danese S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2689-2700. PubMed ID: 32777550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.
    Taxonera C; Sagastagoitia I; Alba C; Mañas N; Olivares D; Rey E
    Aliment Pharmacol Ther; 2020 Jul; 52(2):276-283. PubMed ID: 32359205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
    Turner D; Huang Y; Martín-de-Carpi J; Aloi M; Focht G; Kang B; Zhou Y; Sanchez C; Kappelman MD; Uhlig HH; Pujol-Muncunill G; Ledder O; Lionetti P; Dias JA; Ruemmele FM; Russell RK;
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):727-733. PubMed ID: 32443020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Brenner EJ; Ungaro RC; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD
    Gastroenterology; 2020 Aug; 159(2):481-491.e3. PubMed ID: 32425234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in patients with inflammatory bowel disease.
    Anikhindi SA; Kumar A; Arora A
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
    Wang H; Tu L; Li Y; Bai T; Zou K; Xiao F; Li J; Chen M; Zhang H; Li G; Lu Y; Wang K; Jin S; Yang Y; Zhu L; Hou X
    J Immunol Res; 2020; 2020():2847316. PubMed ID: 33062719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBD in the COVID-19 era: the value of international collaboration.
    Brenner EJ; Ungaro RC; Colombel JF; Kappelman MD
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):887-888. PubMed ID: 32941833
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.
    Singh S; Khan A; Chowdhry M; Bilal M; Kochhar GS; Clarke K
    Gastroenterology; 2020 Oct; 159(4):1575-1578.e4. PubMed ID: 32522507
    [No Abstract]   [Full Text] [Related]  

  • 11. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.
    Al-Ani AH; Prentice RE; Rentsch CA; Johnson D; Ardalan Z; Heerasing N; Garg M; Campbell S; Sasadeusz J; Macrae FA; Ng SC; Rubin DT; Christensen B
    Aliment Pharmacol Ther; 2020 Jul; 52(1):54-72. PubMed ID: 32348598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance.
    Queiroz NSF; Barros LL; Azevedo MFC; Oba J; Sobrado CW; Carlos AS; Milani LR; Sipahi AM; Damião AOMC
    Clinics (Sao Paulo); 2020; 75():e1909. PubMed ID: 32321117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry.
    Windsor JW; Underwood FE; Brenner E; Colombel JF; Kappelman MD; Ungaro R; Zhang X; Kaplan GG
    Am J Gastroenterol; 2020 Nov; 115(11):1923-1924. PubMed ID: 33156119
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
    Khan N; Patel D; Xie D; Pernes T; Lewis J; Yang YX
    Gastroenterology; 2020 Oct; 159(4):1592-1594.e1. PubMed ID: 32574622
    [No Abstract]   [Full Text] [Related]  

  • 15. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.
    Rademaker M; Baker C; Foley P; Sullivan J; Wang C
    Australas J Dermatol; 2020 May; 61(2):158-159. PubMed ID: 32219857
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.
    Allocca M; Fiorino G; Zallot C; Furfaro F; Gilardi D; Radice S; Danese S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2134-2135. PubMed ID: 32360811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
    Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    Allez M; Fleshner P; Gearry R; Lakatos PL; Rubin DT
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S774-S779. PubMed ID: 32722757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.
    Rimondi A; Tontini GE; Mazza S; Caprioli F; Sangiovanni A; Lampertico P; Vecchi M
    Inflamm Bowel Dis; 2020 Sep; 26(10):e128-e129. PubMed ID: 32720979
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
    Caron B; Arondel Y; Reimund JM
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2637-2638. PubMed ID: 32522559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.